Comparative Pharmacology
Head-to-head clinical analysis: GENERLAC versus GLYCOLAX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GENERLAC versus GLYCOLAX.
GENERLAC vs GLYCOLAX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It is metabolized by colonic bacteria to short-chain fatty acids (e.g., lactic, acetic, and formic acids), which osmotically increase intraluminal water content, soften stool, and stimulate peristalsis. In hepatic encephalopathy, the acidic environment reduces intestinal ammonia production and absorption by promoting conversion of NH3 to NH4+.
Osmotic laxative. Polyethylene glycol (PEG) increases intraluminal water volume in the colon by osmosis, promoting stool passage and relieving constipation.
10-45 mL orally once daily, adjusted to produce 2-3 soft stools per day. Maximum 60 mL/day.
17 g (1 heaping tablespoon) dissolved in 4-8 ounces of liquid once daily, orally.
None Documented
None Documented
Not applicable; lactulose is a non-absorbable disaccharide that exerts a local osmotic effect in the colon without systemic absorption. Systemic half-life is not relevant as it does not enter circulation.
Not applicable due to negligible systemic absorption; local colonic transit time approximately 2-4 hours.
Primarily fecal (≥90%) as unchanged drug via colonic excretion; renal elimination is negligible (<1%).
Minimally absorbed; excreted primarily unchanged in feces via osmotic action. Renal excretion negligible (<0.2% absorbed dose).
Category C
Category C
Osmotic Laxative
Osmotic Laxative